ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3,2,Sinus rhythm,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
4,1,Administration site extravasation,Administration site reactions NEC,Administration site reactions,Genrl,N
4,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5,1,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
5,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
5,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
5,4,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
6,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
7,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
7,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
7,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
7,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
8,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
9,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
10,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10,2,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
11,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
11,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
12,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
12,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
12,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
12,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
12,5,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
12,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
12,7,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
12,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
12,9,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
12,10,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
13,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
13,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
14,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
15,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
16,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
16,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
16,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
17,1,Headache,Headaches NEC,Headaches,Nerv,N
17,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
17,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
17,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
17,5,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
17,6,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
18,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
19,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
20,1,Accelerated hypertension,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
21,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
22,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
